Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Design Therapeutics (DSGN): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
8 analysts
Options Flow (P/C)
—
Avg Consensus PT
$16
+71.6%
Highest Price Target
$26
+174.6%
Lowest Price Target
$5
-47.2%
Short Interest
13.4%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | RBC Capital | Leonid Timashev— | +100.6% | $20 → $19 | Maintained | Outperform |
| Oct 2, 2026 | Wells Fargo | Tianqi Hang— | +174.6% | $26 | Initiate | Overweight |